American Cannabis Company, INC
Market Movers (8-K)
OTC.Pink
American Cannabis Company, Inc. announced the immediate departure of Joe Cleghorn as CEO, with James Woodend appointed as the new CEO and Chairman of the Board.
OTC.Pink
American Cannabis Company, Inc. announced the appointment of Griffin Brahms to its Board of Directors, effective May 6, 2026.
OTC.Pink
American Cannabis Company announced the immediate resignation of its CEO, CFO, and Chairman, Ellis Smith, and the appointment of an interim CEO and new board member.
Worse than expected
OTC.Pink
American Cannabis Company, Inc. (AMMJ) has entered into two material definitive agreements, including a significant stock issuance to KTEC, LLC and the transfer of cannabis licenses and assets to Cannabis Depot Colorado Springs Inc., both subject to regulatory approval.
Capital raise
Delay expected
OTC.Pink
American Cannabis Company, Inc. reports the acceptance of Ellis Smith's resignation from the Board of Directors, with the board declining his subsequent attempt to rescind it.
OTC.Pink
Ellis Smith resigned from his positions as director, president, secretary, and treasurer of American Cannabis Company, Inc. and its subsidiaries, effective February 27, 2025.
Quarterly Earnings (10-Q)
OTC.Pink
American Cannabis Company reports a net loss for Q2 2024 and undertakes strategic measures, including debt restructuring and asset sales, to address financial challenges.
Delay expected
Capital raise
Worse than expected
OTC.Pink
American Cannabis Company's Q1 2024 revenue decreased significantly due to reduced consulting and product sales, despite a slight increase in cannabis product revenue.
Delay expected
Capital raise
Worse than expected
Annual Reports (10-K)
OTC.Pink
American Cannabis Company experienced a substantial decrease in revenue in 2023, primarily due to a decline in product and equipment sales, alongside a general market downturn in the cannabis sector.
Capital raise
Worse than expected